Align Technology Introduces Invisalign Clear Aligners for Phase 1 Treatment of Younger Patients With Early Mixed Dentition

Medical Device Investing

Align Technology (NASDAQ:ALGN) today announced it is extending the Invisalign product family with Invisalign First clear aligners, designed with features specifically for younger patients with early mixed dentition (with a mixture of primary/baby and permanent teeth). Phase 1 treatment is early interceptive orthodontic treatment for young patients, traditionally done through arch expanders, or partial metal …

Align Technology (NASDAQ:ALGN) today announced it is extending the Invisalign product family with Invisalign First clear aligners, designed with features specifically for younger patients with early mixed dentition (with a mixture of primary/baby and permanent teeth). Phase 1 treatment is early interceptive orthodontic treatment for young patients, traditionally done through arch expanders, or partial metal braces, before all permanent teeth have erupted – typically at ages 6 through 10 years.

As quoted in the press release:

“Early interceptive orthodontic treatment of children aims to prevent more severe problems or alignment issues that could get worse as they grow, while at the same time providing a foundation for permanent teeth to begin to erupt,” said Dr. Mitra Derakhshan, Align Technology vice president of global clinical. “Younger patients have smaller teeth with shorter crowns and anatomical differences that require specific features for Phase 1 treatment. Invisalign First is the first clear aligner product designed with software driven features specifically for younger patients.”

Click here to read the full press release.

The Conversation (0)
Ă—